PRESS RELEASE published on 05/13/2025 at 07:00, 1 year 5 months ago Inside Information / News release on accounts, results Innate Pharma reports Q1 2025 business update with €15 million investment by Sanofi, FDA Breakthrough Therapy Designation for lacutamab, and cash position of €72.5 million FDA Financial Results Sanofi Innate Pharma Q1 2025
BRIEF published on 05/02/2025 at 15:27, 1 year 5 months ago Sanofi augmente sa participation dans Innate Pharma Capital Actions Franchissement De Seuils Sanofi Innate Pharma
BRIEF published on 05/02/2025 at 15:27, 1 year 5 months ago Sanofi increases its stake in Innate Pharma Capital Actions Crossing Thresholds Sanofi Innate Pharma
PRESS RELEASE published on 05/02/2025 at 15:22, 1 year 5 months ago Franchissement de seuils Déclaration de franchissement de seuils par Sanofi pour Innate Pharma via augmentation de capital Augmentation De Capital Franchissement De Seuils Sanofi Innate Pharma
BRIEF published on 04/29/2025 at 21:05, 1 year 5 months ago Innate Pharma Presents Promising Preclinical Data for IPH4502 at AACR 2025 Preclinical Data Innate Pharma IPH4502 Nectin-4 Antibody Drug Conjugate
BRIEF published on 04/29/2025 at 21:05, 1 year 5 months ago Innate Pharma présente des données précliniques prometteuses pour IPH4502 à l'AACR 2025 Innate Pharma Données Précliniques Conjugué Anticorps-médicament IPH4502 Nectine-4
PRESS RELEASE published on 04/29/2025 at 21:00, 1 year 5 months ago Inside Information / Other news releases Innate Pharma presents preclinical data for IPH4502, a Nectin-4 targeting ADC, showing superior anti-tumor efficacy in multiple cancer models at AACR 2025 Annual Meeting Preclinical Data Innate Pharma IPH4502 AACR 2025 Nectin-4 ADC
PRESS RELEASE published on 04/29/2025 at 21:00, 1 year 5 months ago Informations privilégiées / Autres communiqués Innate Pharma présente les données précliniques prometteuses d'IPH4502, un conjugué anticorps-médicament innovant ciblant Nectine-4, au congrès annuel de l'AACR 2025 Préclinique Innate Pharma Conjugué Anticorps-médicament IPH4502 AACR 2025
BRIEF published on 04/24/2025 at 07:40, 1 year 6 months ago Innate Pharma Secures €15M Sanofi Investment Capital Increase Innate Pharma Sanofi Investment BCMA ANKET Biotech Partnership
BRIEF published on 04/24/2025 at 07:40, 1 year 6 months ago Innate Pharma obtient un investissement de 15 millions d'euros auprès de Sanofi Augmentation De Capital Innate Pharma BCMA ANKET Investissement Sanofi Partenariat Biotechnologique
Published on 10/28/2026 at 12:30, 4 hours 1 minute ago Digi Power X to Announce 2026 Q3 Financial Results and Provide Operations Update on November 13th
Published on 10/28/2026 at 12:30, 4 hours 1 minute ago AI/ML Innovations Announces Advance Notice Provisions
Published on 10/28/2026 at 12:30, 4 hours 1 minute ago Sterling Expands Mineralized Footprint to 2km With Near Surface Intercept in 850m Eastern Step Out
Published on 10/28/2026 at 12:30, 4 hours 1 minute ago Ameriwest Reports Additional High-Grade Copper Results from Historical Drill Core at Bornite Including 71.0 Feet (21.6 Meters) at 8.08% CuEq
Published on 10/28/2026 at 12:15, 4 hours 16 minutes ago BULGOLD Expands Strategic Exploration Position Around the Lutila Gold Project with Two New Exploration Licences
Published on 10/28/2026 at 15:19, 1 hour 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: Vesuvius PLC
Published on 10/28/2026 at 15:18, 1 hour 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle PLC
Published on 10/28/2026 at 15:18, 1 hour 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 10/28/2026 at 15:17, 1 hour 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: Segro PLC
Published on 10/28/2026 at 08:00, 8 hours 31 minutes ago Edenred successfully raises €800 million in a dual-tranche bond offering
Published on 10/28/2026 at 08:00, 8 hours 31 minutes ago Edenred lève avec succès 800 millions d’euros dans le cadre d’une émission obligataire à deux tranches
Published on 10/27/2026 at 18:00, 22 hours 31 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 22 hours 31 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
